In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nidan Laboratories and Healthcare's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ₹-8.37.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Nidan Laboratories and Healthcare's Days Inventory for the
six
months ended in Mar. 2025 was 256.99.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nidan Laboratories and Healthcare's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nidan Laboratories and Healthcare's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.03.
Nidan Laboratories and Healthcare (NSE:NIDAN) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Nidan Laboratories and Healthcare's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nidan Laboratories and Healthcare's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Nidan Laboratories and Healthcare Total Inventories Related Terms
Nidan Laboratories and Healthcare Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nidan Laboratories and Healthcare Total Inventories Chart
Nidan Laboratories and Healthcare Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Total Inventories of ₹5.5 Mil as of Mar. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Total Inventories too high?
Nidan Laboratories and Healthcare's current Total Inventories is ₹5.5 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Total Inventories compare to TMO and DHR?
Nidan Laboratories and Healthcare's Total Inventories of ₹5.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Diagnostics & Research company?
A good Total Inventories depends on the Medical Diagnostics & Research industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Total Inventories is ₹5.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Total Inventories of ₹5.5 Mil. The current Total Inventories is ₹5.5 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Total Inventories is ₹5.5 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nidan Laboratories and Healthcare Business Description
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score
Get the complete analysis for NSE:NIDAN
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NIDAN has been successfully added to your 
